Vermillion Wealth Management’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

Vermillion Wealth Management’s Portfolio VRPX Stock Details VRPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4	Closed	-$5	–	593
2025 Q1	$5	Hold	4	–	–	﹤0.01%	1315
2024 Q4	$38	Buy	+4	New	+$53	﹤0.01%	541

Other funds holding VRPX

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Vermillion Wealth Management's VRPX Position: Q2 2025 in Review

Vermillion Wealth Management sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q2 2025, closing a stake of 4 shares — an estimated $5 sold.

Vermillion Wealth Management first reported a position in VRPX in Q4 2024 and held it in 2 quarters. The position peaked at $38 in Q4 2024. 1 fund tracked by Wall St. Rank holds VRPX as of Q2 2025.

Vermillion Wealth Management reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Vermillion Wealth Management sold 4 Virpax Pharmaceuticals, Inc. Common Stock shares in Q2 2025, an estimated $5.
Vermillion Wealth Management first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q4 2024 and held it in 2 quarters.
Vermillion Wealth Management's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $38 in Q4 2024.
1 fund tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q2 2025.

Based on Vermillion Wealth Management's 13F filing for Q2 2025, filed 17 Jul 2025.